1997
DOI: 10.1016/s0952-7915(97)80136-7
|View full text |Cite
|
Sign up to set email alerts
|

Antibody engineering

Abstract: The development of recombinant techniques for the rapid cloning, expression, and characterization of cDNAs encoding antibody (Ab) subunits has revolutionized the field of antibody engineering. By fusion to heterologous protein domains, chain shuffling, and inclusion of self-assembly motifs, novel molecules such as bispecific Abs can now be generated which possess the subset of functional properties designed to fit the intended application. Rapid technological developments in phage display of peptides and prote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
42
0
2

Year Published

2002
2002
2015
2015

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(44 citation statements)
references
References 104 publications
0
42
0
2
Order By: Relevance
“…irus infection can initiate various antiviral signaling pathways, including the nuclear factor kappa B (NF-B) pathway (1)(2)(3)(4). The NF-B family plays an important role in inflammation and the innate immune response and is composed of five transcription factors, including RelA/p65, RelB, c-Rel, p50/NF-B1, and p52/ NF-B2, that homo-and heterodimerize (3).…”
mentioning
confidence: 99%
“…irus infection can initiate various antiviral signaling pathways, including the nuclear factor kappa B (NF-B) pathway (1)(2)(3)(4). The NF-B family plays an important role in inflammation and the innate immune response and is composed of five transcription factors, including RelA/p65, RelB, c-Rel, p50/NF-B1, and p52/ NF-B2, that homo-and heterodimerize (3).…”
mentioning
confidence: 99%
“…항체 공학을 이용해 제조되는 재조합항체는 특이적 항원 결합력을 갖는 Fv 항체와 Single-chain Fv(ScFv) 항체 (Hayden et al, 1997;Verma et al, 1998) (Bird et al, 1988;Huston et al, 1991 (Nishinaka, et al, 1996) (Fig. 1 and Fig.…”
Section: 서 론unclassified
“…For example, modifications may be made to modulate target binding and pharmacokinetic properties, increase the degree of humanness, or address developability issues that might affect drug safety and shelf life. [8][9][10][11] Many of those tasks are enabled, or at least greatly facilitated, by structure-based considerations on the atomic level. 12 The large number of publicly available antibody crystal structures that have been solved during the last 25 y is an indicator for the relevance of this class of proteins.…”
Section: Introductionmentioning
confidence: 99%